Найти в Дзене
Fact.MR Research

Sales of Qpcr Reagents are Projected to Reach US$ 4.90 Billion By 2033: Fact.MR Analysis

3 мин
The global qPCR reagents market is valued at US$ 2.27 billion in 2023 and is predicted to increase at a CAGR of 8% from 2023 to 2033, as per a new industry analysis by Fact.MR, a market research and competitive intelligence provider. Quantitative PCR (qPCR), also known as real-time PCR or quantitative real-time PCR, is a PCR-based technique that combines the amplification of a target DNA sequence with the measurement of the concentration of that DNA species in the reaction. Download a Free Sample Copy of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8312?AS Increasing cases of infectious diseases and rising prevalence of genetic disorders are driving the need for qPCR reagents. The cases of tuberculosis (TB) are also increasing rapidly across the globe. Rising investments from public and private sectors in qPCR research programs, the rapidly growing gene sequencing industry, and advancements in the biotech and pharma sector are driving the qPCR reagents market grow

The global qPCR reagents market is valued at US$ 2.27 billion in 2023 and is predicted to increase at a CAGR of 8% from 2023 to 2033, as per a new industry analysis by Fact.MR, a market research and competitive intelligence provider.

Quantitative PCR (qPCR), also known as real-time PCR or quantitative real-time PCR, is a PCR-based technique that combines the amplification of a target DNA sequence with the measurement of the concentration of that DNA species in the reaction.

Download a Free Sample Copy of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8312?AS

Increasing cases of infectious diseases and rising prevalence of genetic disorders are driving the need for qPCR reagents. The cases of tuberculosis (TB) are also increasing rapidly across the globe.

  • According to a WHO report, TB is the leading cause of death for people living with HIV. Around 1.6 million people died due to TB worldwide in 2021.

Rising investments from public and private sectors in qPCR research programs, the rapidly growing gene sequencing industry, and advancements in the biotech and pharma sector are driving the qPCR reagents market growth.

North America holds a dominating position in the global qPCR reagents market. This can be attributed to the rising cases of cancer and the presence of key market players. During the next 10 years, Europe and Asia Pacific markets are expected to grow healthily due to the rapid advancements in the field of genome sequencing.

Key Takeaways from Market Study

  • The global qPCR reagents market is expected to reach US$ 4.90 billion by 2033.
  • The market in China is predicted to expand at a high CAGR of 7.5% during the projected period.
  • Demand for dye-based qPCR reagents is expected to rise at a CAGR of 8.5% during the next 10 years.
  • Sales of probes & primer-based qPCR reagents are anticipated to increase at a 7% CAGR.

“Rising need for drug discovery & pharmacogenomics and technological advancements in the field of life sciences are fuelling global qPCR reagents market growth,” says a Fact.MR analyst.

Recent Market Developments

  • Two cutting-edge life science reagent and instrument firms, Takara Bio USA, Inc. and BioExcel Diagnostics, developed and validated a new high-throughput and comprehensive technique for diagnosing contagious diseases based on syndromic markers in October 2022.
  • Roche formally unveiled the AVENIO Tumor Tissue CGP Kit in October 2021. The kit allows laboratories to expand their oncology research in addition to the current CGP portfolio offered by Roche and Foundation Medicine.
  • Roche announced the CE-IVD launch of their automated digital pathology algorithms in January 2021. These include uPath Dual ISH and uPath HER2 (4B5) image categorization. Artificial intelligence is used in image analysis algorithms to support pathologists in making quicker, more accurate patient diagnoses and therapies for breast cancer. This innovation in breast cancer image analysis can help determine the best treatment plan for each patient.

Key Companies Profiled

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Promega Corporation
  • Qiagen NV
  • Quanta Biosciences, Inc.
  • Sigma-Aldrich Corporation
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

Key Segments of qPCR Reagents Industry Research

  • By Detection Method :Dye-based qPCR Reagents
    Probes & Primer-based qPCR Reagents
  • By Packaging Type :qPCR Core Kits
    qPCR Master Mixes
  • By Application :Diagnostic
    Research
    Forensic
  • By End User :Hospitals & Diagnostic Centers
    Research Laboratories & Academic Institutes
    Pharma & Biotech Companies
    Clinical Research Organizations
    Forensic Laboratories
  • By Region :North America
    Latin America
    Europe
    East Asia
    South Asia & Oceania
    MEA

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global qPCR reagents market, presenting historical demand data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.

The study divulges essential insights on the market on the basis of detection method (dye-based qPCR reagents, probes & primer-based qPCR reagents), packaging type (qPCR core kits, qPCR master mixes), application (diagnostic, research, forensic), and end user (hospitals & diagnostic centers, research laboratories & academic institutes, pharma & biotech companies, clinical research organizations, forensic laboratories), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8312?AS 

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : sales@factmr.com